Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.

Saved in:
Bibliographic Details
Title: Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.
Authors: Pinto N; Seattle Children's Hospital, Seattle, Washington, USA.; Department of Pediatrics, University of Washington, Seattle, Washington, USA., Navarro SL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Rimorin C; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wurscher M; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Hawkins DS; Seattle Children's Hospital, Seattle, Washington, USA.; Department of Pediatrics, University of Washington, Seattle, Washington, USA., McCune JS; Department of Hematologic Malignances Translational Sciences, City of Hope, Duarte, California, USA.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Nov; Vol. 68 (11), pp. e29203. Date of Electronic Publication: 2021 Jul 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-5017
DOI:10.1002/pbc.29203